13-39655760-T-A
Variant summary
Our verdict is Likely benign. Variant got -2 ACMG points: 2P and 4B. PM2BP4_Strong
The NM_020751.3(COG6):c.34T>A(p.Ser12Thr) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant was absent in control chromosomes in GnomAD project. In-silico tool predicts a benign outcome for this variant. 15/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Consequence
NM_020751.3 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -2 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
COG6 | NM_020751.3 | c.34T>A | p.Ser12Thr | missense_variant | Exon 1 of 19 | ENST00000455146.8 | NP_065802.1 | |
COG6 | NM_001145079.2 | c.34T>A | p.Ser12Thr | missense_variant | Exon 1 of 19 | NP_001138551.1 | ||
COG6 | XM_011535168.2 | c.34T>A | p.Ser12Thr | missense_variant | Exon 1 of 20 | XP_011533470.1 | ||
COG6 | NR_026745.1 | n.134T>A | non_coding_transcript_exon_variant | Exon 1 of 20 |
Ensembl
Frequencies
GnomAD3 genomes Cov.: 34
GnomAD4 exome Data not reliable, filtered out with message: AC0;AS_VQSR AF: 0.00 AC: 0AN: 1441100Hom.: 0 Cov.: 41 AF XY: 0.00 AC XY: 0AN XY: 715096
GnomAD4 genome Cov.: 34
ClinVar
Submissions by phenotype
Inborn genetic diseases Uncertain:1
The c.34T>A (p.S12T) alteration is located in exon 1 (coding exon 1) of the COG6 gene. This alteration results from a T to A substitution at nucleotide position 34, causing the serine (S) at amino acid position 12 to be replaced by a threonine (T). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at
Publications
No publications associated with this variant yet.